Acronym | PharmaBoost |
|---|---|
Project ID | EE-LV00007 |
Implementation period | 01.09.2023.–30.04.2025. |
Programme | Estonia–Latvia programme 2021–2027 implemented under the European territorial cooperation goal (Interreg) |
Programme priority | 2 – Jointly and smartly growing businesses |
Programme specific objective | 2.1 – Enhancing sustainable growth and competitiveness of SMEs and job creation in SMEs, including by productive investments |
Project coordinator | TBD Pharmatech Ltd. |
Project partner | Latvian Institute of Organic Synthesis (LIOS) |
Project leader at LIOS | Dr. Gints Smits |
Total budget | € 582 436.25 |
EU contribution | € 465 949.00 |
LIOS budget | € 115 580.00 |
The primary goal of the project PharmaBoost is to pioneer an economically and environmentally sustainable production technology of an active pharmaceutical ingredient crucial for a vital smoking cessation medication. Implementation of the project will contribute to advancing pharmaceutical development and promoting pharmaceutical innovations within the Baltic States.
The TBD Pharmatech and LIOS partnership aims to establish a more resilient pharmaceutical landscape reinforced by a proficient workforce, cutting-edge infrastructure, and cross-border cooperation.